Lifespan participating in Phase 3 clinical trial of Novavax vaccine

By
-
LIFESPAN CORP. is vaccinating trial participants in the Phase 3 clinical trial for the Novavax Inc. vaccine against COVID-19. /COURTESY LIFESPAN
PROVIDENCE – Lifespan Corp. began vaccinating volunteer participants this week as one of 110 host sites in the Phase 3 clinical trial for the Novavax Inc. vaccine against COVID-19. Lifespan will help with the trial by signing up volunteers and giving them either the vaccine or the placebo, then tracking their responses over a two-year…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

If you have already logged in and are still seeing this message, please refresh the page as your browser is caching the old content.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

RELATED ARTICLESMORE FROM AUTHOR

No posts to display